oxybutynin chloride)
Extended-release tablets
15 mg
Rx only
Ditropan XL®and OROS®are registered
trademarks of ALZA Corporation.
DITROPAN XL
oxybutynin chloride tablet, extended release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:50458-805
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
oxybutynin chloride (oxybutynin) oxybutynin chloride 5 mg
Inactive Ingredients
Ingredient Name Strength
cellulose acetate
hypromelloses
lactose
magnesium stearate
polyethylene glycols
titanium dioxide
polysorbate 80
sodium chloride
butylated hydroxytoluene
Product Characteristics
Color YELLOW (pale yellow) Score no score
Shape ROUND Size 8mm
Flavor Imprint Code 5;XL
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:50458-805-01 100 TABLET, EXTENDED RELEASE ( TABLET) in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020897 06/26/1999
DITROPAN XL
oxybutynin chloride tablet, extended release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:50458-810
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
oxybutynin chloride (oxybutynin) oxybutynin chloride 10 mg
Inactive Ingredients
Ingredient Name Strength
cellulose acetate
hypromelloses
lactose
magnesium stearate
polyethylene glycols
titanium dioxide
polysorbate 80
sodium chloride
butylated hydroxytoluene
Product Characteristics
Color PINK Score no score
Shape ROUND Size 8mm
Flavor Imprint Code 10;XL
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:50458-810-01 100 TABLET, EXTENDED RELEASE ( TABLET) in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020897 06/26/1999
DITROPAN XL
oxybutynin chloride tablet, extended release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:50458-815
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
oxybutynin chloride (oxybutynin) oxybutynin chloride 15 mg
Inactive Ingredients
Ingredient Name Strength
cellulose acetate
hypromelloses
lactose
magnesium stearate